The article linked below suggests that using specific types of anti-depressants (tricyclic and NDRI’s) increases survival in lung cancer in both clinically and statistically significant ways. No benefit is seen with SSRI’s however.
NDRI means norepinephrine and dopamine reuptake inhibitors, one of which is Wellbutrin, which happens to be a medication I have been taking now for about half a year. It seems like a really easy thing to try to extend survival so I thought maybe other people here would be interested.
10/2015 Chest xray found a nodule as part of a physical (no symptoms).
01/2016 Upper left lobe lingula preserving lobectomy stage 2b for 1.9 cm invasive adenocarcinoma with additional 2 mm AIS nodule found in pathology.
03-05/2016 Sixteen weeks of adjuvant cisplatin/vinorelbine.
07/2016 Durvalumab adjuvant clinical trial discontinued after 1st dose knocked out thyroid.
12/2016 Revised to stage 1b (due to VPI) after new guidelines for multifocal lepidic lung cancer.
07/2018 Next scan.